EcoDrugPlus

Adrenoceptor Alpha 1d

Ensembl ID : ENSATEG00000017749
Gene Symbol: ADRA1D
2 Cross references
195 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSATEG00000008669
Gene Symbol: ADRA2A
3 Cross references
176 Possible Orthologues:

Adrenoceptor Alpha 2b

Ensembl ID : ENSATEG00000019770
Gene Symbol: ADRA2B
3 Cross references
175 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSATEG00000019239
Gene Symbol: ADRA2C
3 Cross references
156 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSATEG00000022306
Gene Symbol: ADRA2C
3 Cross references
162 Possible Orthologues:

Adrenoceptor Beta 1

Ensembl ID : ENSATEG00000021670
Gene Symbol: ADRB1
1 Cross references
163 Possible Orthologues:

Adrenoceptor Beta 2, Surface A

Ensembl ID : ENSATEG00000001246
Gene Symbol: ADRB2A
3 Cross references
196 Possible Orthologues:

Adrenoceptor Beta 3a

Ensembl ID : ENSATEG00000023273
Gene Symbol: ADRB3A
3 Cross references
197 Possible Orthologues:

Alpha-1a Adrenergic Receptor

Ensembl ID : ENSATEG00000006442
Gene Symbol: LOC113160006
2 Cross references
192 Possible Orthologues:

Alpha-2a Adrenergic Receptor

Ensembl ID : ENSATEG00000004483
Gene Symbol: LOC113159673
2 Cross references
156 Possible Orthologues:

Alpha-Synuclein-Like

Ensembl ID : ENSATEG00000017006
Gene Symbol: LOC113159884
2 Cross references
189 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSATEG00000019580
Gene Symbol: AOC1
3 Cross references
233 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).